Myomo Inc - Asset Resilience Ratio

Latest as of March 2026: 11.70%

Myomo Inc (MYO) has an Asset Resilience Ratio of 11.70% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$4.30 Million
Cash + Short-term Investments

Total Assets

$36.75 Million
All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Myomo Inc's Asset Resilience Ratio has changed over time. Check Myomo Inc (MYO) strategic asset index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Myomo Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Myomo Inc worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $4.30 Million 11.7%
Total Liquid Assets $4.30 Million 11.70%

Asset Resilience Insights

  • Moderate Liquidity: Myomo Inc has 11.70% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company has significant short-term investments, indicating active treasury management.

Myomo Inc Industry Peers by Asset Resilience Ratio

Compare Myomo Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Demant A/S
CO:DEMANT
Medical Devices -2.59%
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Vieworks Co. Ltd
KQ:100120
Medical Devices 7.81%
Emvision Medical Devices Ltd
AU:EMV
Medical Devices 0.06%
Respiri Ltd
AU:RSH
Medical Devices 0.46%
Diagnostic Medical Systems SA
PA:ALDMS
Medical Devices 1.48%
Implanet SA
PA:ALIMP
Medical Devices 0.55%
Oncosil Medical Ltd
AU:OSL
Medical Devices 0.00%

Annual Asset Resilience Ratio for Myomo Inc (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Myomo Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 47.61% $18.39 Million $38.64 Million -11.25pp
2024-12-31 58.86% $24.87 Million $42.24 Million -1.94pp
2023-12-31 60.80% $8.87 Million $14.58 Million +8.20pp
2022-12-31 52.61% $5.35 Million $10.16 Million -24.65pp
2021-12-31 77.25% $15.52 Million $20.10 Million -5.97pp
2020-12-31 83.22% $12.24 Million $14.71 Million +15.55pp
2019-12-31 67.67% $4.47 Million $6.60 Million -11.31pp
2018-12-31 78.98% $6.54 Million $8.28 Million -13.75pp
2017-12-31 92.73% $12.96 Million $13.97 Million +44.66pp
2016-12-31 48.07% $797.17K $1.66 Million --
pp = percentage points

About Myomo Inc

NYSE MKT:MYO USA Medical Devices
Market Cap
$40.18 Million
Market Cap Rank
#23448 Global
#5044 in USA
Share Price
$1.04
Change (1 day)
+9.47%
52-Week Range
$0.64 - $2.11
All Time High
$579.30
About

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.… Read more